Clinical trial

18F FLT Imaging Studies of Treatment Response for Lung Cancer and Thymoma

NCT01610544

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention 3'-deoxy-3'-18F fluorothymidine (FLT) Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention PET/CT scan Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

18F FLT Imaging Studies of Treatment Response for Lung Cancer and Thymoma

Design: INTERVENTIONAL · Status: WITHDRAWN · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2012-05-10

PhasePHASE2

Conditions

Carcinoma, Non-Small-Cell Lungunresolved

Thymus Neoplasmsunresolved

Interventions

3'-deoxy-3'-18F fluorothymidine (FLT)DRUG

PET/CT scanOTHER

Sponsors & collaborators

National Cancer Institute (NCI)lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01610544 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.